CORRECTED-Novartis's $90 mln Swiss factory to help solve cell therapy bottleneck
November 28, 2019 at 13:00 PM EST
Swiss drugmaker Novartis's new $90 million cell and gene therapy factory in northern Switzerland is on track to begin commercial production of its cell therapy Kymriah for cancer in 2020.
